CSIMarket
 
Cvs Health Corporation  (CVS)
Other Ticker:  
 
 

Cvs Health Income Statement Quarterly

CVS


Select the Financial Report:   Period:   Fiscal Year:

INCOME STATEMENT
(Quarterly GAAP In millions $)

(Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Premiums Earned, Net 30,391.00 24,657.00 25,108.00 24,352.00
Revenue From Contract With Customer Excluding Assessed Tax 53,724.00 61,298.00 60,539.00 58,147.00
Other Revenue 4,322.00 3,809.00 3,274.00 2,779.00
Total Revenue 88,437.00 93,813.00 89,764.00 88,921.00 85,278.00
Cost of Goods and Services Sold 48,073.00 57,419.00 54,688.00 53,536.00 51,455.00
Policyholder Benefits and Claims Incurred, Net, Health 27,803.00 22,518.00 21,499.00 21,782.00 20,448.00
Gross Profit 12,561.00 13,876.00 13,577.00 13,603.00 13,375.00
Selling, Administration, Marketing - - - - -
Depriciation & Amortization - - - - -
Research & development - - - - -
Impairment of Long-Lived Assets to be Disposed of - - - - 349.00
Other operatinig exp. /-income 10,290.00 9,996.00 9,887.00 10,369.00 9,580.00
Share based plans expense - - - - -
Restructuring Costs And Asset Impairment Charges - 507.00 - - -
Total operating costs including COS 86,166.00 90,440.00 86,074.00 85,687.00 81,832.00
Operating income/-loss 2,271.00 3,373.00 3,690.00 3,234.00 3,446.00
Other Deductions / - Income
Interest expense 716.00 690.00 693.00 686.00 589.00
Interest income - - - - -
Net interest expense/-income 716.00 690.00 693.00 686.00 589.00
Net Investment Income -454.00 -268.00 -277.00 -274.00 -334.00
Income from affiliates - - - - -
Depreciation - - - - -
Financing Loss/ -Income - - - - -
Other loss/ -income 429.00 246.00 255.00 252.00 312.00
Total costs & expenses 86,857.00 91,108.00 86,745.00 86,351.00 82,399.00
Income /-loss before income taxes 1,580.00 2,705.00 3,019.00 2,570.00 2,879.00
Income taxes expenses/-benefit 456.00 658.00 754.00 656.00 737.00
Income after income taxes 1,124.00 2,047.00 2,265.00 1,914.00 2,142.00
Net income/-loss of other equity - - - - -
Income/-loss from cont. Ops. 1,124.00 2,047.00 2,265.00 1,914.00 2,142.00
Accounting change - - - - -
Discontinued operations - - - - -
Extraordinary items - - - - -
Net Income/-loss 1,124.00 2,047.00 2,265.00 1,914.00 2,142.00
Noncontrolling interests -11.00 -1.00 -4.00 -13.00 -6.00
Prefered dividends - - - - -
Other - - - - -
Income/-loss to shareholder 1,113.00 2,046.00 2,261.00 1,901.00 2,136.00
EBIT 2,296.00 3,395.00 3,712.00 3,256.00 3,468.00
EBITD 3,434.00 4,529.00 4,839.00 4,360.00 4,469.00
EBITDA 3,434.00 4,529.00 4,839.00 4,360.00 4,469.00


Per Share (GAAP Quarterly, in $) (Mar 31 2024)
I. Quarter
(Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
Basic EPS (excl. extra items) 0.88 1.59 1.76 1.48 1.66
   Extraordinary items 0.00 0.00 0.00 0.00 0.00
Basic Net EPS 0.88 1.59 1.76 1.48 1.66
Basic shares outstanding (Mill. of Units) 1,260.00 1,287.00 1,287.00 1,283.00 1,283.00
   EPS other shares - - - - -
Diluted Net EPS 0.88 1.59 1.75 1.48 1.65
Diluted average shares (Mill. of Units) 1,267.00 1,289.64 1,290.00 1,287.00 1,291.00
Dividend per share 0.665 0.605 0.605 0.605 0.605



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com